node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
C14orf80 | DEFB104A | ENSP00000376307 | ENSP00000320813 | chromosome 14 open reading frame 80 | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.583 |
C14orf80 | DEFB107A | ENSP00000376307 | ENSP00000334681 | chromosome 14 open reading frame 80 | defensin, beta 107A; Has antibacterial activity (Potential) | 0.700 |
C14orf80 | DEFB4A | ENSP00000376307 | ENSP00000303532 | chromosome 14 open reading frame 80 | defensin, beta 4A; Has antibacterial activity (Potential) | 0.418 |
CCR6 | DEFB1 | ENSP00000339393 | ENSP00000297439 | chemokine (C-C motif) receptor 6; Receptor for a C-C type chemokine. Binds to MIP-3- alpha/LARC and subsequently transduces a signal by increasing the intracellular calcium ions level | defensin, beta 1; Has bactericidal activity (By similarity) | 0.965 |
CCR6 | DEFB103B | ENSP00000339393 | ENSP00000324633 | chemokine (C-C motif) receptor 6; Receptor for a C-C type chemokine. Binds to MIP-3- alpha/LARC and subsequently transduces a signal by increasing the intracellular calcium ions level | defensin, beta 103B; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.683 |
CCR6 | DEFB4A | ENSP00000339393 | ENSP00000303532 | chemokine (C-C motif) receptor 6; Receptor for a C-C type chemokine. Binds to MIP-3- alpha/LARC and subsequently transduces a signal by increasing the intracellular calcium ions level | defensin, beta 4A; Has antibacterial activity (Potential) | 0.576 |
DEFB1 | CCR6 | ENSP00000297439 | ENSP00000339393 | defensin, beta 1; Has bactericidal activity (By similarity) | chemokine (C-C motif) receptor 6; Receptor for a C-C type chemokine. Binds to MIP-3- alpha/LARC and subsequently transduces a signal by increasing the intracellular calcium ions level | 0.965 |
DEFB1 | DEFB103A | ENSP00000297439 | ENSP00000320951 | defensin, beta 1; Has bactericidal activity (By similarity) | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.788 |
DEFB1 | DEFB103B | ENSP00000297439 | ENSP00000324633 | defensin, beta 1; Has bactericidal activity (By similarity) | defensin, beta 103B; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.783 |
DEFB1 | DEFB104A | ENSP00000297439 | ENSP00000320813 | defensin, beta 1; Has bactericidal activity (By similarity) | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.414 |
DEFB1 | DEFB4A | ENSP00000297439 | ENSP00000303532 | defensin, beta 1; Has bactericidal activity (By similarity) | defensin, beta 4A; Has antibacterial activity (Potential) | 0.808 |
DEFB1 | DEFB4B | ENSP00000297439 | ENSP00000424598 | defensin, beta 1; Has bactericidal activity (By similarity) | defensin, beta 4B; Has antibacterial activity (Potential) | 0.580 |
DEFB1 | TLR4 | ENSP00000297439 | ENSP00000363089 | defensin, beta 1; Has bactericidal activity (By similarity) | toll-like receptor 4 | 0.502 |
DEFB103A | DEFB1 | ENSP00000320951 | ENSP00000297439 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 1; Has bactericidal activity (By similarity) | 0.788 |
DEFB103A | DEFB103B | ENSP00000320951 | ENSP00000324633 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 103B; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | 0.576 |
DEFB103A | DEFB104A | ENSP00000320951 | ENSP00000320813 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 104A; Has antimicrobial activity. Synergistic effects with lysozyme and DEFB103 | 0.473 |
DEFB103A | DEFB105A | ENSP00000320951 | ENSP00000334330 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 105A; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB107A | ENSP00000320951 | ENSP00000334681 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 107A; Has antibacterial activity (Potential) | 0.473 |
DEFB103A | DEFB4A | ENSP00000320951 | ENSP00000303532 | defensin, beta 103A; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | defensin, beta 4A; Has antibacterial activity (Potential) | 0.634 |
DEFB103B | CCR6 | ENSP00000324633 | ENSP00000339393 | defensin, beta 103B; Exhibits antimicrobial activity against Gram-positive bacteria S.aureus and S.pyogenes, Gram-negative bacteria P.aeruginosa and E.coli and the yeast C.albicans. Kills multiresistant S.aureus and vancomycin-resistant E.faecium. No significant hemolytic activity was observed | chemokine (C-C motif) receptor 6; Receptor for a C-C type chemokine. Binds to MIP-3- alpha/LARC and subsequently transduces a signal by increasing the intracellular calcium ions level | 0.683 |